Total Revenue

8% increase (from ~$494.27M in Q4 2023 to $533.78M in Q4 2024)

Strong revenue growth was achieved through continued benefits from prior-period initiatives such as price increases, new product launches, and acquisitions that enhanced geographic reach. These same factors, which previously drove significant Q3 and Q4 momentum, are now sustaining an 8% YoY uplift. " "

United States Revenue

~8.5% increase (from $454.75M in Q4 2023 to $492.89M in Q4 2024)

US revenue growth reflects persistent demand in the domestic market, building on previous period successes from strategic product introductions and pricing adjustments that had already boosted US sales in earlier quarters. This has resulted in an 8.5% increase YoY. " "

Operating Income

12% increase (from $77.24M in Q4 2023 to $86.75M in Q4 2024)

Improved operating income is linked to higher gross margins and operational efficiencies implemented in previous periods. Enhanced cost management, driven by favorable product mix and effective SG&A controls, continues to boost profitability, as seen with a 12% YoY increase. " "

Net Income

8% increase (from $50.28M in Q4 2023 to $54.51M in Q4 2024)

Net income gains resulted from the sustained revenue growth and margin expansion efforts observed in previous periods. Despite increased expenses in earlier quarters, improved cost efficiencies and favorable sales trends have driven an 8% YoY increase in net income. " "

Earnings per Share

10% increase (Basic EPS from $1.6 to $1.78 and Diluted EPS from $1.6 to $1.77 in Q4 2024)

EPS improvement is attributable to higher net income combined with share repurchase activity that reduced the share count, thereby enhancing per-share metrics. This reflects ongoing financial discipline and value creation trends noted in the previous quarters. " "